The largest database of trusted experimental protocols

9 protocols using ab6858

1

Recombinant Protein Immunoblotting Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Each recombinant protein (45 μl) was diluted by sample loading buffer (15 μl) and boiled at 100°C for 10 min. All recombinant proteins were then separated on 12% sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS‐PAGE) gels and transferred to polyvinylidene fluoride (PVDF) membranes using semidry Trans‐Blot SD (Bio‐Rad, Corning Inc., NY, USA) system. PVDF Membranes were blocked at 37°C water‐jacket incubator for 2 h with 5% (w/v) skim milk diluted in phosphate‐buffered saline (PBS) and then washed 3 times with PBST (PBS containing 0.05% Tween‐20). After being washed three times, PVDF membranes were incubated with mice sera (1:200) or mixed TB‐positive sera (1:100) diluted in PBST. After being washed, PVDF membranes were incubated at 37°C for 1 h with horseradish peroxidase (HRP)‐conjugated anti‐mouse IgG (1:20 000) (ab6728, Abcam) or HRP‐conjugated anti‐human IgG (1: 20 000) (ab6858, Abcam) respectively.
+ Open protocol
+ Expand
2

Mucosal and Systemic Immune Responses

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole blood and vaginal fluids were collected as described previously on day 0 before the initial vaccination, at days 30 and 60 after the first vaccinations, and at months 1 and 6 after the last vaccination. The specific serum IgG and vaginal IgA antibodies were calculated by ELISA as described elsewhere15 (link) using goat anti-human IgG H&L (horseradish peroxidase [HRP]) antibody (ab6858; Abcam, Canada; 1:1,000 dilution) and goat anti-human IgA alpha chain (HRP) (ab97215; Abcam, Canada; 1:1,000 dilution).
Approximately 105 PBMCs and 105 cervical lymphocytes were isolated from each subject as described previously23 (link) on day 0 before the initial vaccination, at days 30 and 60 after first vaccinations, and at months 1 and 6 after the last vaccination. Accordingly, Th1 type IFN-γ and antigen-specific CTLs (HLA-A*0201-restricted CTL)25 (link) against HPV-16 E6 were measured after stimulation with 10 μg/mL major histocompatibility complex (MHC) class I and HPV-16-derived CTL epitopes (synthesized HPV-16 E649–58 and HPV-16 E629–38 peptides, respectively) using a human IFN-γ ELISpot kit according to manufacturer instructions (R&D Systems, USA). and spots were counted under a dissection microscope with digital assistance. All assays were performed in triplicate.
+ Open protocol
+ Expand
3

Western Blot Analysis of Cell Proliferation and Apoptosis Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells from the various treatment groups were lysed using radio-immunoprecipitation assay buffer (Beyotime Institute of Biotechnology). Protein determination by was performed via the BCA method and total protein was isolated. Equal amounts (25 µg) total protein were separated on a 10% gel via sodium dodecyl sulfate polyacrylamide gel electrophoresis and transferred to a polyvinylidene difluoride (PVDF) membrane. The PVDF membrane was blocked with 5% milk for 1 h at room temperature. The PVDF membrane was then washed with TBST (0.1% Tween-20) three times The PVDF membrane was incubated with primary antibodies against Ki-67 (1:1,000; cat. no. ab15580; Abcam), proliferating cell nuclear antigen (PCNA; 1:1,000; cat. no. ab280088; Abcam), Bcl-2 (1:1,000; cat. no. ab32124; Abcam) and Bax (1:1,000; cat. no. ab182734; Abcam) at 4˚C overnight. Secondary horseradish peroxidase (HRP)-rabbit antibody (1:5,000; cat. no. ab6858; Abcam) was then added to the membrane, after which it was incubated at room temperature for 2 h. The PVDF membrane was then washed with TBST three times and developed using 5 ml enhanced chemiluminescence substrate (Roche Diagnostics; cat. no. 11684817910) for 3 times and ImageJ software (version k 1.45; National Institutes of Health) was used for analysis.
+ Open protocol
+ Expand
4

Immunohistochemical Analysis of SENP1, Ki67, and p-STAT5

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemistry was performed to detect the expression of SENP1, Ki67, and p-STAT5. The detailed process has been described in our previous article [17 ]. In brief, the formalin-fixed, paraffin-embedded specimens were sliced into 4 µm tissue sections, then depolished with xylene and rehydrated with an alcohol solution. After antigen retrieval, the tissue sections were incubated with anti-SENP1, anti-Ki67, or anti-p-STAT5 primary antibody for 24 hours (h) at 4 °C, and then washed with PBS and incubated with peroxidase-conjugated goat anti-human/mouse secondary antibody (1:200 dilution, #ab6858 and #ab150113, Abcam, USA) for 1 h at room temperature. Five fields were randomly selected from each section under a light microscope (100×, BX51, Olympus, Japan) fitted with a digital camera (DP72, Olympus, Japan). Image-Pro Plus 6.0 software was used to quantitively analyze the images. Quantification of SENP1, Ki67, and p-STAT5 was determined by mean of integrated optical density (IOD).
+ Open protocol
+ Expand
5

SARS-CoV-2 ACE2 Antibody Binding Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
MaxiSorp 96-well flat-bottomed plates were coated with 50 μl of 125 nM recombinant human or mouse ACE2 protein in PBS at room temperature for 1 h. All washes were performed three times using PBS and 0.1% Tween-20 and all incubations were performed for 1 h at room temperature. Coated plates were washed and blocked by incubation with 4% skim milk solution. Plates were washed and then incubated with 50 μl of 125 nM of anti-ACE2 monoclonal antibodies. The plates were washed and incubated with horseradish peroxidase (HRP)-conjugated goat anti-human IgG secondary antibodies (ab6858, Abcam, 1:5,000). After a final wash, 50 μl of azino-bis-3-ethylbenthiazoline-6-sulfonic acid (ABTS liquid substrate; Sigma-Aldrich) was added and incubated in the dark at room temperature for 20 min and 50 μl of 1% SDS was used to stop the reaction. Absorbance was read at 405 nm and all samples were done in duplicate.
+ Open protocol
+ Expand
6

Zika Virus Antibody ELISA Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Nunc MaxiSorp plates (Thermo Fisher Scientific, Waltham, MA) were coated with ZIKV E or E domain III protein (1 µg/mL) and incubated at 4°C overnight. After blocking for 2 h, the plates were washed six times with phosphate-buffered saline (PBS) and transfected with antibody supernatants at a 1:2 dilution with blocking buffer or a serial dilution of purified mAbs. Secondary antibody (goat anti-human IgG; ab6858; Abcam, Cambridge, UK) was applied at a 1:5000 dilution in blocking solution and then the plates were incubated at room temperature for 1 h, and TMB substrate. Absorbance values were determined at 450 nm using a BioTek plate reader (BioTek Instruments, Winooski, VT).
+ Open protocol
+ Expand
7

Proteomic Analysis of Human Sperm and Vaginal Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human sperm, seminal plasma, and VK2/E6E7 cells (vaginal epithelial cell line used as a negative control [34] (link)) (VK2/E6E7, ATCC Cat# CRL-2616, RRID: CVCL-6471) were lysed in radioimmunoprecipitation assay (RIPA) buffer, denatured with SDS and used as antigen targets in the western blot assay. 20–30 µg of protein were loaded onto a 4–12% gradient polyacrylamide gel, and after electrophoresis, proteins were transferred to PVDF membranes. The blots were blocked with 5% powdered milk and washed with 0.1% TBS-T. All primary antibodies were used at a concentration of 10 µg/mL; anti-mouse (Santa Cruz Cat# sc-2005, RRID: AB_631736, Santa Cruz Biotechnology, Santa Cruz, CA, USA) and anti-rat (Abcam Cat# ab97057, RRID: AB_10680316, Cambridge, MA, USA) secondary antibodies were used at a 1:20,000 dilution, and the anti-human secondary antibody (Abcam Cat# ab6858, RRID: AB_955433) was used at a 1:5,000 dilution. Blots were developed in ECL substrate (ThermoFisher Scientific, Waltham, MA, USA). To cleave off the N-linked glycan epitope, sperm cell lysates were treated with PNGase F according to the manufacturer's protocol (New England Biolabs, Ipswich, MA, USA).
+ Open protocol
+ Expand
8

BpOmpW-specific Antibody Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Microtiter plates were coated with purified BpOmpW at 0.5 μg/ml in sodium bicarbonate buffer (pH 9.4) at 4°C overnight, after which the coating solution was removed and the plates blocked with 1% FBS (7524; Sigma) solution in PBS at room temperature for 1 h. The wells were washed three times with 0.05% Tween 20 in PBS using a plate washer (5165040; Thermo Scientific). All serum samples were serially diluted (fivefold) in PBS containing 1% FBS and 100 μl added to the wells in triplicate at room temperature (RT) for 2 h. The plates were then washed three times with 0.05% Tween 20 in PBS, as described above, before the addition of anti-mouse immunoglobulin G (IgG), IgG1, or IgG2a–horseradish peroxidase (HRP)-conjugated antibodies (ab97023, ab97240, ab97245, respectively; Abcam, Cambridge, UK) at RT for 1 h. Then, the TMB (3,3′,5,5′-tetramethylbenzidine) substrate was added and incubated until the color developed, at which time the reactions were stopped with 2 M sulfuric acid and the plates read at 450 nm. For the detection of BpOmpW-specific IgG in human plasma, the same protocol was applied using anti-human IgG–HRP antibody (ab6858; Abcam) in place of anti-mouse IgG antibodies. All the HRP-conjugated antibodies were diluted 1:5000 in PBS containing 1% FBS. The color intensity at OD450 correlated with the amount of specific antibodies in the sera.
+ Open protocol
+ Expand
9

Her-2 Inhibition Assay with Immune Sera

Check if the same lab product or an alternative is used in the 5 most similar protocols
Briefly, 96-well plates were coated with recombinant Her-2 D4 (1 μg/well) overnight at 4°C and then blocked with 1% BSA/PBST (200 μL per well) for 2 h at room temperature. The diluted immune sera (1:10) were added into wells for 1 h at room temperature, followed by Herceptin (Roche Pharma (Schweiz) Ltd) for 1 h at room temperature. Pre-immune sera were used as controls. Subsequently, the wells were incubated with anti-human IgG HRP conjugates (Abcam, ab6858) and the TMB Microwell Substrate. The OD450 nm was measured. The following formula was used to calculate the percent inhibition: (ODpre − ODpost)/ODpre × 100%.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!